Recursion Pharmaceuticals (Group)

https://www.recursionpharma.com

LinkedIn: https://www.linkedin.com/company/4990022

Recursion is a clinical-stage biotechnology company decoding biology to radically improve lives by industrializing drug discovery, development and beyond through disruptive innovation. Enabling its mission is the Recursion Operating System, a platform built across diverse technologies that continuously expands one of the world's largest proprietary biological and chemical datasets, the Recursion Data Universe. Recursion leverages sophisticated machine-learning algorithms to distill from its dataset the Recursion Map, a collection of hundreds of billions of searchable inferences across biology and chemistry unconstrained by human bias. By commanding massive experimental scale — up to millions of wet lab experiments weekly — and massive computational scale — owning and operating one of the most powerful supercomputers in the world, Recursion is uniting technology, biology and chemistry to advance the future of medicine. The Company is proudly headquartered in Salt Lake City, where it is a founding member of BioHive, the Utah life science industry collective. Recursion also has offices in Toronto, Montreal and the San Francisco Bay Area. *

	Start	2013-01-01 established
	Industry	AI-based drug discovery / AI-based drug development
	Industry 2	artificial intelligence (AI) / machine learning (ML)
	Person	Gibson, Chris (Recursion Pharmaceuticals 201907 CEO + Co-Founder)

	Region	Salt Lake City, UT
	Country	United States (USA)
	Street	41 South Rio Grande Street
	City	84101 Salt Lake City, UT
	Tel	+1-385-269-0203
		Address record changed: 2024-08-08

Basic data	Employees	D: 101 to 500 (2021-02-17)
	Currency	USD
	Annual sales	3,962,000 (revenue, total, consolidated (2020) 2020-12-31)
	Profit	-87,006,000 (2020-12-31)
	Cash	262,126,000 (2020-12-31)

		* Document for »About Section«: Recursion Pharmaceuticals, Inc.. (12/7/21). "Press Release: Recursion Announces Transformational Collaboration with Roche and Genentech in Neuroscience and Oncology, Advancing Novel Medicines to Patients Using Machine Learning and High Content Screening

		Record changed: 2024-08-08